ResMed Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Apr 24 | Sell€85,249 | Karen Drexler | Individual | 425 | €200.58 | |
22 Feb 24 | Sell€4,609,380 | Peter Farrell | Individual | 23,535 | €219.27 | |
27 Nov 23 | Sell€418,896 | Brett Sandercock | Individual | 3,000 | €139.63 |
Insider Trading Volume
Insider Buying: RME insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,673 | 0.00182% |
State or Government | 128,511 | 0.0875% |
Individual Insiders | 1,149,223 | 0.782% |
General Public | 42,620,807 | 29% |
Institutions | 102,982,856 | 70.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,769,766 | €3.4b | 0.15% | 0.06% | |||
12,562,891 | €2.4b | 0.06% | 0.04% | |||
7,027,694 | €1.4b | 0% | 0.68% | |||
6,757,151 | €1.3b | 0.07% | 0.05% | |||
3,423,880 | €659.0m | -0.35% | 0.06% | |||
2,465,165 | €474.5m | 69.1% | 0.53% | |||
2,311,200 | €444.8m | 10,800% | 1.03% | |||
1,820,708 | €350.4m | 123% | 0.06% | |||
1,636,546 | €315.0m | 0% | 0.14% | |||
1,491,272 | €287.0m | 32.6% | 0.06% | |||
1,422,126 | €273.7m | -2.05% | 0.05% | |||
1,413,145 | €272.0m | -39.4% | 0.02% | |||
1,380,605 | €265.7m | 0.78% | 0.09% | |||
1,360,110 | €261.8m | 0% | 0.02% | |||
1,159,387 | €223.1m | -3.18% | 0.06% | |||
1,105,996 | €212.9m | -1.45% | 0.04% | |||
1,047,936 | €201.7m | 0% | 0.51% | |||
975,254 | €187.7m | 22.3% | 0.03% | |||
931,319 | €179.3m | 1.79% | 0.05% | |||
898,147 | €172.9m | 4.04% | 0.03% | |||
775,599 | €149.3m | -3.8% | 0.02% | |||
756,273 | €145.6m | -3.76% | 0.43% | |||
739,634 | €142.4m | 38.9% | 0.02% | |||
711,228 | €136.9m | -5.14% | 0.07% | |||
653,987 | €125.9m | -0.1% | 0.04% |